Gail A. Spiridigliozzi

2.2k total citations
44 papers, 1.3k citations indexed

About

Gail A. Spiridigliozzi is a scholar working on Genetics, Cognitive Neuroscience and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Gail A. Spiridigliozzi has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Genetics, 22 papers in Cognitive Neuroscience and 13 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Gail A. Spiridigliozzi's work include Genetics and Neurodevelopmental Disorders (23 papers), Autism Spectrum Disorder Research (22 papers) and Down syndrome and intellectual disability research (13 papers). Gail A. Spiridigliozzi is often cited by papers focused on Genetics and Neurodevelopmental Disorders (23 papers), Autism Spectrum Disorder Research (22 papers) and Down syndrome and intellectual disability research (13 papers). Gail A. Spiridigliozzi collaborates with scholars based in United States, Switzerland and South Korea. Gail A. Spiridigliozzi's co-authors include Allyn McConkie‐Rosell, Ave M. Lachiewicz, Priya S. Kishnani, Deborah V. Dawson, James H. Heller, Jennifer A. Sullivan, B. Kent Houston, Jack Tarleton, Xin Ding and Mary C. Phelan and has published in prestigious journals such as Journal of Personality and Social Psychology, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Gail A. Spiridigliozzi

43 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gail A. Spiridigliozzi United States	23	659	498	310	255	175	44	1.3k
Kate Lawrence United Kingdom	23	601 0.9×	615 1.2×	70 0.2×	256 1.0×	241 1.4×	52	1.8k
Jonas Bybjerg‐Grauholm Denmark	21	565 0.9×	207 0.4×	125 0.4×	388 1.5×	241 1.4×	68	1.4k
Jack Euesden United Kingdom	10	659 1.0×	132 0.3×	96 0.3×	251 1.0×	170 1.0×	15	1.3k
Wietske A. Ester Netherlands	15	287 0.4×	365 0.7×	73 0.2×	194 0.8×	251 1.4×	43	1.3k
J.I.M. Egger Netherlands	24	539 0.8×	525 1.1×	81 0.3×	479 1.9×	558 3.2×	196	2.1k
Jeanne E. Savage United States	19	561 0.9×	238 0.5×	67 0.2×	317 1.2×	399 2.3×	53	1.6k
Sabine E. Mous Netherlands	15	225 0.3×	311 0.6×	79 0.3×	142 0.6×	151 0.9×	31	855
I Kremer Israel	22	128 0.2×	248 0.5×	113 0.4×	295 1.2×	261 1.5×	80	1.8k
Anne Tournay United States	13	187 0.3×	179 0.4×	161 0.5×	141 0.6×	111 0.6×	20	1.1k
Kingsley Wong Australia	27	1.2k 1.8×	793 1.6×	165 0.5×	243 1.0×	667 3.8×	89	1.9k

Countries citing papers authored by Gail A. Spiridigliozzi

Since Specialization

Citations

This map shows the geographic impact of Gail A. Spiridigliozzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gail A. Spiridigliozzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gail A. Spiridigliozzi more than expected).

Fields of papers citing papers by Gail A. Spiridigliozzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gail A. Spiridigliozzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gail A. Spiridigliozzi. The network helps show where Gail A. Spiridigliozzi may publish in the future.

Co-authorship network of co-authors of Gail A. Spiridigliozzi

This figure shows the co-authorship network connecting the top 25 collaborators of Gail A. Spiridigliozzi. A scholar is included among the top collaborators of Gail A. Spiridigliozzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gail A. Spiridigliozzi. Gail A. Spiridigliozzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Spiridigliozzi, Gail A., et al.. (2025). Exploring the use of the National Institutes of Health Toolbox Cognition Battery with children and adolescents with Pompe disease: Preliminary findings. Molecular Genetics and Metabolism. 144(3). 109043–109043.

Kenney‐Jung, Daniel, Grace A. Stafford, Michael D. Malinzak, et al.. (2025). Infantile-onset Pompe disease entering adulthood: Insights from 2 decades of enzyme replacement therapy experience. Genetics in Medicine. 27(12). 101590–101590. 1 indexed citations

Kenney‐Jung, Daniel, Gail A. Spiridigliozzi, Walter F. Wiggins, et al.. (2023). Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease. Molecular Genetics and Metabolism. 141(2). 108119–108119. 12 indexed citations

Santoro, Stephanie L., Sarah J. Hart, Nora Horick, et al.. (2023). Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 193(4). e32070–e32070. 1 indexed citations

Spiridigliozzi, Gail A., Tatyana Adayev, Allyn McConkie‐Rosell, et al.. (2023). High performing male with fragile X syndrome with an unmethylated FMR1 full mutation: The relevance of clinical and genetic correlations. SHILAP Revista de lepidopterología. 11(6). e7371–e7371. 3 indexed citations

Spiridigliozzi, Gail A., et al.. (2017). Cognitive and academic outcomes in long-term survivors of infantile-onset Pompe disease: A longitudinal follow-up. Molecular Genetics and Metabolism. 121(2). 127–137. 30 indexed citations

Spiridigliozzi, Gail A., Sarah J. Hart, James H. Heller, et al.. (2016). Safety and efficacy of rivastigmine in children with Down syndrome: A double blind placebo controlled trial. American Journal of Medical Genetics Part A. 170(6). 1545–1555. 18 indexed citations

Spiridigliozzi, Gail A., James H. Heller, & Priya S. Kishnani. (2012). Cognitive and adaptive functioning of children with infantile Pompe disease treated with enzyme replacement therapy: Long‐term follow‐up. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 160C(1). 22–29. 22 indexed citations

Spiridigliozzi, Gail A., James H. Heller, Laura E. Case, Harrison N. Jones, & Priya S. Kishnani. (2011). Early cognitive development in children with infantile Pompe disease. Molecular Genetics and Metabolism. 105(3). 428–432. 20 indexed citations

10.

Heller, James H., et al.. (2010). Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: Long-Term Follow-Up. Journal of Child and Adolescent Psychopharmacology. 20(6). 517–520. 16 indexed citations

11.

Kishnani, Priya S., James H. Heller, Gail A. Spiridigliozzi, et al.. (2010). Donepezil for treatment of cognitive dysfunction in children with Down syndrome aged 10–17. American Journal of Medical Genetics Part A. 152A(12). 3028–3035. 63 indexed citations

12.

Wehbe, Ramsey M., et al.. (2009). When to tell and test for genetic carrier status: Perspectives of adolescents and young adults from fragile X families. American Journal of Medical Genetics Part A. 149A(6). 1190–1199. 19 indexed citations

13.

Heller, James H., Gail A. Spiridigliozzi, Blythe G. Crissman, et al.. (2006). Safety and Efficacy of Rivastigmine in Adolescents with Down Syndrome: A Preliminary 20-Week, Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 16(6). 755–765. 33 indexed citations

14.

Heller, James H., et al.. (2006). Clinical trials in children with Down syndrome: Issues from a cognitive research perspective. American Journal of Medical Genetics Part C Seminars in Medical Genetics. 142C(3). 187–195. 21 indexed citations

15.

Heller, James H., Gail A. Spiridigliozzi, Jennifer A. Sullivan, et al.. (2002). Donepezil for the treatment of language deficits in adults with Down syndrome: A preliminary 24‐week open trial. American Journal of Medical Genetics Part A. 116A(2). 111–116. 44 indexed citations

16.

McConkie‐Rosell, Allyn, Gail A. Spiridigliozzi, Jennifer A. Sullivan, Deborah V. Dawson, & Ave M. Lachiewicz. (2001). Longitudinal study of the carrier testing process for fragile X syndrome: Perceptions and coping. American Journal of Medical Genetics. 98(1). 37–45. 1 indexed citations

17.

McConkie‐Rosell, Allyn, Gail A. Spiridigliozzi, Jennifer A. Sullivan, Deborah V. Dawson, & Ave M. Lachiewicz. (2000). Longitudinal study of the carrier testing process for fragile X syndrome: Perceptions and coping. American Journal of Medical Genetics. 98(1). 37–45. 29 indexed citations

18.

Lachiewicz, Ave M., Gail A. Spiridigliozzi, Allyn McConkie‐Rosell, et al.. (1996). A fragile X male with a broad smear on southern blot analysis representing 100–500 CGG repeats and no methylation at theEagI site of the FMR-1 gene. American Journal of Medical Genetics. 64(2). 278–282. 18 indexed citations

19.

Hove, Johan L.K. Van, Gail A. Spiridigliozzi, R Heinz, et al.. (1995). Fryns syndrome survivors and neurologic outcome. American Journal of Medical Genetics. 59(3). 334–340. 29 indexed citations

20.

McConkie‐Rosell, Allyn, Ave M. Lachiewicz, Gail A. Spiridigliozzi, et al.. (1993). Evidence that methylation of the FMR-I locus is responsible for variable phenotypic expression of the fragile X syndrome.. PubMed. 53(4). 800–9. 138 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact